Titlebook: Hormone Related Cancer Mechanistic and Nanomedicines; Challenges and Prosp Mahfoozur Rahman,Waleed H Almalki,Khalid S Alharbi Book 2022 The

BAN

Pancreatic Cancer: Nanoparticle Targeted Therapy Via Epidermal Growth Factor Receptor,tough to detect, hard to diagnose, and early to metastasize. Hence, by the time symptoms are diagnosed it may be at higher phases and could have been spread to other organs. Pancreatic cancer is a malignant neoplasm that arises from the cells of pancreas, a glandular organ made of both endocrine and

emulsify

Nanocarriers-Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead,lity have been steadily increasing. Over the last decade, advancements in diagnosis, pancreatectomy surgery, radiotherapy technique, and systemic therapies have made advances, but relatively small improvements in patient outcomes. Furthermore, in pancreatic cancer, most of the chemotherapy drugs res

遺產(chǎn)

Pancreatic Cancer Treatment by Using Theragnostic Nanoparticles,rious approaches have been implemented for the detection of PC at an early stage. Apart from this several chemotherapeutic drugs are suggested for patients diagnosed with PC but their applications are restricted due to systemic toxicity due to long-term usage. Nanotechnology-based therapeutic approa

破譯密碼

Nanomedicine-Based Combinational Therapy for Breast Cancer,ficient to cater to this fatal disease. The complex pathophysiology of the disease demands multidrug therapy or combinational drug therapy, in which the two drugs show the nonoverlapping mode of action. Drug combinations such as doxorubicin and cyclophosphamide, bevacizumab and paclitaxel, lapatinib

rods366

Nanoliposomal System for Breast Cancer Therapy,into clinical applications. Liposomes are well-established and effective drug delivery systems, extensively used in cancer therapy including breast cancer. In this chapter nanoliposomes designed with the breast cancer targeting feature and drug release triggering functions are emphasized. The chapte

OUTRE

Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer, and human epidermal growth factor receptor-2. In the past several decades, the absence of specific targets resulted in a shortage of innovative treatments, and chemotherapy remained the dominant treatment option. However, TNBC has a lower survival rate and an increased likelihood of recurrence and

inculpate

BUOY

Concept of Nanomedicine in Endocrine Hormone Cancer Treatment,er and badly affects the endocrine system of the patient. Currently, due to the alarming increase in the endocrine cancer patients, there is a need for nanotechnology like therapeutic options to treat the endocrine cancer. This chapter describes about the steroid-based hormone receptors in the cance

Congeal

Neurocognitive Underpinning of Neurological Disorders: Role of Default Mode Network,ted with many neurological disorders. However, this network has recently shown activation during high-order social cognitive tasks attributed to self-referential processing and theory of mind. Furthermore, in several disorders with deficits in social cognition, or disrupted physiology including auti

Estrogen